Adva Biotechnology
Ramat Gan, Israel· Est.
Adva delivers an AI‑enabled, closed‑system platform for automated autologous cell therapy manufacturing.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Adva delivers an AI‑enabled, closed‑system platform for automated autologous cell therapy manufacturing.
OncologyImmunology
Technology Platform
ADVA X3® automated cell processing system powered by CAMP® (Continuous Adaptive Multi‑Parameter) technology, delivering real‑time sensor monitoring and AI‑driven adaptive control of autologous cell manufacturing.
Opportunities
The shift toward decentralized, point‑of‑care cell‑therapy manufacturing and the need for AI‑enabled process control create strong demand for Adva’s platform across hospitals and CMOs.
Risk Factors
Regulatory approval of the manufacturing system, adoption barriers in established GMP facilities, and competition from larger bioprocessing vendors could impede market penetration.
Competitive Landscape
Adva competes with established platform providers such as Lonza, Miltenyi Biotec, and Thermo Fisher, differentiating itself through integrated AI‑driven adaptive control and a single‑use closed system designed for hospital‑based production.